Trial intelligence / Profile preview

Tin Mesoporphyrin for Neonatal Hyperbilirubinemia

NCT00004381Phase 2Completed

Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Start
Dec 1999
Modality
Orthosteric Ligands, Light/Condition-Responsive Prodrugs
Countries
1
01

Overview

A Phase 2 trial of stannsoporfin in neonatal hyperbilirubinemia, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Started Dec 1999; status: completed.

02

Drugs

stannsoporfin
03

Conditions

neonatal hyperbilirubinemia

Beyond the preview

Go deeper on NCT00004381.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00004381.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call